Search results
Biogen Inc. (NASDAQ:BIIB) Receives $286.50 Consensus Target Price from Analysts
ETF DAILY NEWS· 7 hours agoShares of Biogen Inc. (NASDAQ:BIIB – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the twenty-six brokerages that are covering the ...
Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab (Revised)
Zacks via Yahoo Finance· 18 hours agoIf Eli Lilly's (LLY) donanemab is approved by the FDA, it will become the second drug approved by...
Cim Investment Management Inc. Trims Position in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 1 day agoCim Investment Management Inc. decreased its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 4.2% in the fourth quarter, according to its most recent Form 13F filing ...
Biogen (BIIB) & Eisai's Leqembi sBLA Gets FDA Acceptance
Zacks via Yahoo Finance· 5 days agoFDA accepts Biogen's (BIIB) partner Eisai's sBLA for a maintenance intravenous dosing version of...
Gabelli Funds LLC Has $3.80 Million Stock Position in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 6 days agoGabelli Funds LLC trimmed its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 0.5% during the fourth quarter, according to its most recent disclosure with the ...
Biogen Inc. (NASDAQ:BIIB) Stock Position Trimmed by Stephens Inc. AR
ETF DAILY NEWS· 6 days agoStephens Inc. AR cut its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 2.8% during the 4th quarter, according to the company in its most recent filing with the Securities ...
BIOGEN INC. (NASDAQ: BIIB) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class...
Morningstar· 5 days agoDo you, or did you, own shares of Biogen Inc. (NASDAQ: BIIB)? Did you lose money in your investment in Biogen Inc.? Bernstein Liebhard LLP announces that a securities class ...
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit
Morningstar· 5 days agoThe Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Biogen Inc. ("Biogen" or the "Company ...
FDA Advisers Like Lilly’s Alzheimer’s Drug. It’s Good News for Biogen.
Barrons.com· 4 days ago“Leqembi has had a lackluster launch thus far due to various administrative challenges and hurdles,”...
Biogen Inc. Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges BIIB Investors with Losses to...
Morningstar· 5 days agoThe law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District ...